fbpx
Call 512-407-8628

Mild Cognitive Impairment

Mild Cognitive Impairment Clinical Trials

What is Mild Cognitive Impairment?

Mild cognitive impairment (MCI) is a condition in which an individual has mild, but measurable, changes in memory and/or thinking abilities.  Approximately 15 to 20 percent of adults age 65 or older have MCI.  These changes are noticeable to family and friends; however, are not generally severe enough to interfere with one’s activities of daily life.  People with MCI, especially MCI involving memory problems (also known as Amnestic MCI or Mild Neurocognitive Disorder), are more likely to develop Alzheimer’s disease or other types of dementia than people without MCI.  However, MCI does not always lead to dementia.  For some, MCI remains stable, for others MCI may be caused by other treatable factors.  As such, it is important for individuals with concerns about their memory or thinking seek help from a qualified healthcare professional for evaluation, diagnosis and possible treatment. (Source:  Alzheimer’s Association and APA)

Like the rest of our bodies, our brains change as we age. Many people become aware of gradually changes in memory and thinking as they grow older. For example, it may take longer to recall someone’s name or remember a word.

However, consistent and increasing concern about memory or thinking problems may suggest mild cognitive impairment.  Symptoms of MCI may include one or more of the following (Source:  Mayo Clinic):

  • Increasing problems remembering things
  • Forgetting important appointments or social engagements
  • Losing your train of thought, or the thread of conversations, movies or books
  • Feeling increasingly overwhelmed by making complex plans, taking decisions or understanding instructions
  • Having problems finding one’s way around familiar environments
  • Acting more impulsively or having problems with judgment
  • Family and friends often notice these changes

Senior Adults Specialty Research is currently conducting clinical trials of investigational medications for the treatment of mild cognitive impairment.  Qualified participants will receive all research related care and study medication at no cost.

If you or a loved one is interested in applying to participate in a clinical trial for mild cognitive impairment, or would like to schedule a memory screening, please contact us at (512) 407-8628.